Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection [8] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 3, 2005, Pages 310-311

  Pérez Roldán, Francisco ^a   González Carro, Pedro ^a   Villafáñez García, María Concepción ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; DOCETAXEL; LAMIVUDINE; MITOXANTRONE; PREDNISONE;

CANCER CHEMOTHERAPY; DISEASE EXACERBATION; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SEROLOGY;

ACUTE DISEASE; ADENINE; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; PHOSPHONIC ACIDS; PROSTATIC NEOPLASMS; VIRUS ACTIVATION;

EID: 12144283946     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200501203520324     Document Type: Letter

References (5)

1. Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003;348:808-16.
2. Ahmed A, Keeffe EB. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol 1999;94:249-51.
3. Reshef R, Sbeit W, Tur-Kaspa R, Lamivudine in the treatment of acute hepatitis B. N Engl J Med 2000;343:1123-4.
4. Bruno R, Sacchi P, Filice C, Filice G. Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient. Am J Gastroenterol 2001;96:255.
5. Wiegand J, Tischendorf JJ, Nashan B, et al. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. Z Gastroenterol 2004;42:15-8.